Date: Wednesday, October 13
Time: 10:20 – 11:20 CDT
Track 1
Date: Wednesday, October 13
Time: 10:20 – 11:20 CDT
Track 1
Automated Insulin Delivery Systems in Paediatrics: Experience with the MiniMedTM 670G, 770G and 780G Systems
10:20 – 10:25 | Introduction | Prof. Robert Vigersky |
10:25 – 10:40 | Clinical Evidence in young children < 7 years | Prof. Thomas Danne |
10:40 – 10:55 | Clinical Evidence in Children & Adolescents | Prof. Ohad Cohen |
10:55 – 11:10 | Best practices with the MiniMedTM 780G System | Prof. Tadej Battelino |
11:10 – 11:20 | Questions & Answers | Prof. Robert Vigersky |
Date: Wednesday, October 13
Time: 14:10 – 15:10 CDT
Track 1
Patient Selection for Sustaining Outcomes in the Pediatric Population with the t:slim X2™ insulin pump with Control-IQ™ technology
Introduction | Jordan Pinsker |
Emotions and Outcomes of a Pediatric Virtual Camp | Valentino Cherubini |
Sustaining Outcomes with AID in the Pediatric Population | Molly McElwee Malloy |
Patient-Selection for Hybrid Closed Loop Systems | Katharine Barnard-Kelly |
Date: Thursday, October 14
Time: 06:30 – 07:00 CDT
Track 1
Importance of Screening for Type 1 Diabetes
Speaker: Linda A. DiMeglio, MD, MPH – Indiana University School of Medicine, Riley’s Children Hospital
Screening for islet autoantibodies along with monitoring and counseling has been shown to improve clinical outcomes in type 1 diabetes (T1D). Screening studies have demonstrated reduced rates of diabetic ketoacidosis, lower rates of hospitalization at time of onset of stage 3 (clinical) T1D, and improved glycemic control with lower HbA1c. Diagnosis of T1D usually occurs suddenly and often dramatically. Diagnosis of early-stage T1D together with counseling has been shown to help ease the transition to stage 3 (insulin-dependent) T1D for patients and caregivers.
Date: Thursday, October 14
Time: 06:30 – 07:00 CDT
Track 2
The MiniMedTM 780G system in paediatrics: Meet the Experts from around the Globe
Chair: Prof. Ohad Cohen
06:30 – 06:55 | Initiating the MiniMedTM 780G system in children | Prof. Goran Petrovski |
06:45 – 07:00 | Follow-up of children using the MiniMedTM 780G system | Dr. Jennifer McVean |
Date: Thursday, October 14
Time: 10:20 – 11:20 CDT
Track 1
Empowering new Generations: Diabetes Management in the Age of Connectivity
10:20 – 10:25 | Introduction | Tadej Battelino |
10:25 – 10:40 | Evolving care in Type 1 diabetes: Outcomes with 2nd-generation basal insulin analogs | Thomas Danne |
10:40 – 10:55 | Time-in-range and quality of life: New perspectives for young people with diabetes | Frank J. Snoek and David Maahs |
10:55 – 11:15 | Managing diabetes in challenging times: Addressing the evolving unmet needs of pediatric populations | Panel discussion:
Tadej Battelino |
11:15– 11:20 | Summary and Close | Tadej Battelino |
Date: Thursday, October 14
Time: 15:50 – 16:50 CDT
Track 1
Moving from Therapeutic Inertia to Therapeutic Action with Real-Time CGM (RT-CGM)
Moderator: Christine Pospisil, RD, LD, CDE, Director, Clinical Education, Dexcom (United States)
Speaker: Daniel DeSalvo, MD, Assistant Professor of Pediatrics in the Section of Diabetes and Endocrinology, Baylor College of Medicine, Texas Children’s Hospital (United States)
It can be a challenge to push past status quo and tempting to settle for “good enough” when aiming to achieve optimal glycemic outcomes for youth with type 1 diabetes. In this presentation you will hear the latest research for effective diabetes management including:
Date: Friday, October 15
Time: 09:10 – 10:10 CDT
Track 1
How early is too early? Experience with initiation of pump therapy in young children
Introduction | Dr. Trang Ly |
Early implementation of Omnipod in very young children & adolescents | Dr. Peter Adolfsson |
Novel use of a pump post pancreatectomy for congenital hyperinsulinism | Dr. Paul Thornton |
Experience with the use of advanced technology in children with diabetes | Ms Jennifer Boyd |
Q&A | All |